Skip to main content
Premium Trial:

Request an Annual Quote

Biocore to be AnaSpec's Aussie Distributor

NEW YORK (GenomeWeb News) – Life sciences distributor Biocore has reached an agreement to distribute AnaSpec’s products in Australia, the San Jose, Calif.-based AnaSpec said Tuesday.
 
AnaSpec offers three primary technologies, including peptides, detection reagents, and combinatorial chemistry. It focuses on a line of biochemicals and reagents for basic research, high-throughput screening, and drug discovery, and it offers custom services including peptide synthesis, antibody production, and assay development.
 
Biocore, which is headquartered in Sydney, offers several product areas, including antibodies, proteins, assays, enzymes, and immunotoxins.

The Scan

Booster for At-Risk

The New York Times reports that the US Food and Drug Administration has authorized a third dose of the Pfizer-BioNTech SARS-CoV-2 vaccine for people over 65 or at increased risk.

Preprints OK to Mention Again

Nature News reports the Australian Research Council has changed its new policy and now allows preprints to be cited in grant applications.

Hundreds of Millions More to Share

The US plans to purchase and donate 500 million additional SARS-CoV-2 vaccine doses, according to the Washington Post.

Nature Papers Examine Molecular Program Differences Influencing Neural Cells, Population History of Polynesia

In Nature this week: changes in molecular program during embryonic development leads to different neural cell types, and more.